profit from every $100 of sales.
$0$100
Cardinal Health
$281.10+1.06% today
+36.4% in 1 year
1-year low $182.501-year high $281.10
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $41.62 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Cardinal Health sold, what it kept, and what it did with the cash.
Sales went from $181 billion in 2022 to $223 billion in 2025, with $1.56 billion of profit last year.
SalesProfit
Cardinal Health handed back 68% of the cash it generated last year.
Buybacks $765M$494M
Free cash flow 2025$1.9B
Bought back its own shares$765M
Paid as dividends$494M
Cash vs. debt$3.9B vs. $8.5B
Cardinal Health vs. similar companies
Cardinal Health grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Cardinal Health | 41.6× · Expensive | ||
 McKesson | 26.7× · Fair price | ||
 Cencora | 44.1× · Expensive | ||
 Sigma Healthcare | 63.0× · Very expensive | ||
 Henry Schein | 23.9× · Fair price |
AI analysis
An AI analyst reads Cardinal Health's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 152,922 | 162,467 | 181,326 | 204,979 | 226,827 | 222,578 | |
| 6,868 | 6,778 | 6,484 | 6,874 | 7,414 | 8,168 | |
| -4,098 | 472 | 1,648 | 1,789 | 2,130 | 2,322 | |
| -2,621 | 1,286 | 55 | 1,439 | 1,962 | 3,106 | |
| -3,696 | 611 | -938 | 330 | 852 | 1,561 | |
| -12.61 | 2.08 | -3.35 | 1.00 | 3.45 | 6.45 | |
| 4.5% | 4.2% | 3.6% | 3.4% | 3.3% | 3.7% | |
| -2.7% | 0.3% | 0.9% | 0.9% | 0.9% | 1.0% | |
| -2.4% | 0.4% | -0.5% | 0.2% | 0.4% | 0.7% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 40,766 | 44,453 | 43,878 | 43,349 | 45,121 | 53,122 |
| Cash | 2,771 | 3,407 | 4,717 | 4,076 | 5,133 | 3,874 |
| Total debt | 6,800 | 6,200 | 5,315 | 4,701 | 5,092 | 8,527 |
| Total liabilities | – | – | 44,584 | 46,306 | 48,333 | 55,756 |
| 1,789 | 1,791 | -709 | -2,958 | -3,213 | -2,781 | |
| 293 | 294 | 279 | 262 | 247 | 242 | |
| -32.5% | 5.0% | -10.9% | 33.9% | 52.6% | 31.8% | |
| -206.6% | 34.1% | 132.3% | -11.2% | -26.5% | -56.1% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 1,960 | 2,429 | 3,175 | 2,844 | 3,762 | 2,397 | |
| 375 | 400 | 387 | 481 | 511 | 547 | |
| 1,585 | 2,029 | 2,788 | 2,363 | 3,251 | 1,850 | |
| Dividends paid | 569 | 573 | 559 | 525 | 499 | 494 |
| 350 | 200 | 1,000 | 2,000 | 750 | 765 | |
| 90 | 89 | 81 | 96 | 121 | 244 |
Valuation
- 41.6×
- 26.6×
- –
- -21.5×
- 0.3×
- 35.1×
- 22.4×
- 2.8%
- 2.4%
- 1.0%
Profitability
- 3.7%
- 1.0%
- 0.7%
- 1.2%
- 34.0%
- 38.8%
- -55.7%
- 2.8%
- 15.7%
- –
Growth
- +7.8%
- –
- −43.1%
- +0.9%
- −3.3%
Financial health
- 1.2×
- -3.08
- 15.7%
- 7.2×
- 0.88
- 0.48
- 4.42
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 2%of 963
Bottom 25%of 894
Bottom 30%of 632
Bottom 40%of 908
Top 38%of 991
What analysts expect
- Average price target
- $253.38
- Range
- $235.00 – $275.00
- 10 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 3.17 | 2.79 | +13.6% |
| Feb 5, 2026 | 2.63 | 2.34 | +12.4% |
| Oct 30, 2025 | 2.55 | 2.18 | +17.0% |
| Aug 12, 2025 | 2.08 | 2.04 | +2.0% |
| May 1, 2025 | 2.35 | 2.17 | +8.3% |
| Jan 30, 2025 | 1.93 | 1.74 | +10.9% |
| Nov 1, 2024 | 1.88 | 1.62 | +16.0% |
| Aug 14, 2024 | 1.84 | 1.73 | +6.4% |
1.0%of the share price, paid each year
On $1,000 invested$10a year at today's yield, before tax
+0.9%2020 to 2025
Raised1 yearin a row, in our data
Paid per share, each year
$1.50 in 2015 → $2.03 in 2025
How safe it looks
31.6% of its profit
Room to growStretchedMore than it earns: 26.7%
News
Cardinal Infrastructure (CDNL) Detracts Amid Margin Pressures and Outlook CutYahoo Finance · Oct 27, 2026Will Alphabet Break Warren Buffett's Cardinal Rule of Investing?Yahoo Finance · Sep 6, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
59No pass
Benjamin Graham
34No pass
Philip Fisher
43No pass
Peter Lynch
32No pass
Joel Greenblatt
33No pass
Charlie Munger
56No pass
Terry Smith
60Pass
Questions about Cardinal Health
Is Cardinal Health a good stock to buy?
A business with weak numbers, but the price is high. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Cardinal Health AI analysis
What does Cardinal Health do?
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It is in Medical Distribution, based in Dublin, OH, United States, with 53,084 employees.
Does Cardinal Health pay a dividend?
Yes. At today's price the dividend is 1.0% a year, about 32% of its yearly profit. In 2025 it paid out $494 million in dividends.
Is Cardinal Health stock halal?
Yes. Cardinal Health passes our halal screen: its business is permitted and its debt is 13% of its market value, under the 30% limit. How we check
How has Cardinal Health stock done over the past year?
Up 36.4% over the past twelve months, to $281.10. It traded between $182.50 and $281.10, close to its high.
Who are Cardinal Health's competitors?
The largest listed companies in the same industry are McKesson, Cencora, Sigma Healthcare and Henry Schein. The peers table on this page compares their profit, growth and price with Cardinal Health's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.